Pulmatrix, Inc. (PULM) : 10-year performance

Pulmatrix, Inc., a clinical stage biotechnology company, focused on development of novel inhaled therapeutic products to prevent and treat respiratory and other diseases with unmet medical needs in the United States.

• Sector: Healthcare
• Industry: Biotechnology
• Full Time Employees: 22
• Founded by David Alan Edwards, Mark J. Gabrielson, Alexander M. Klibanov, and Robert S. Langer, Jr. in April 2003 
• Headquartered in Framingham, Massachusetts
• http://www.pulmatrix.com

IPO: March 7, 2014

Nov 13, 2024: Pulmatrix, Inc. (NASDAQ:PULM) announced a definitive merger agreement with Cullgen Inc.